Project Grant R21AI190445
Award Date
7/16/25
Completion Date
6/30/27
Dollars Obligated
$481K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This federal Project Grant award of $668,488.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to investigate the role of the VP4 protein from rotavirus (RV) in enabling cell-to-cell transmission and viral pathogenesis. The Washington University, through its Office of Sponsored Research Services Division, is the prime awardee for this 5-year project that...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is supporting research to investigate how human intestinal epithelial cells respond to and defend against rotavirus infection. The key products and services to be delivered include: Conducting research to unravel how rotavirus infection activates the STING pathway in intestinal epithelial cells, leading to the selective...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $593,021.00 to Washington University to conduct a mechanistic investigation of a rotavirus auxiliary protein, NSP6, and its role in countering host immune defenses. The 5-year project, starting on June 20, 2025 and ending on May 31, 2030, aims to define the key structural features of NSP6 that enable immune...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $128,052 to Virginia Polytechnic Institute & State University (Virginia Tech) to investigate the role of the Rift Valley Fever Virus (RVFV) non-structural small (NSS) protein in modulating the host autophagy pathway. The project aims to define the molecular mechanism of the NSS-LC3 interaction and assess its impact...
This Project Grant award, valued at $430,170.00 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA Program 93.855 Allergy and Infectious Diseases Research, supports research to identify genetic determinants of neurotropism in Enterovirus D68 (EV-D68). The overarching goal is to utilize a human spinal cord organoid (HSCO) model to determine viral genetic factors that enable EV-D68 to target the central nervous system and cause acute flaccid myelitis, a...
This $583,047 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how Rift Valley Fever Virus (RVFV) disseminates from the site of infection in the skin to the central nervous system (CNS). The project aims to establish the routes and mechanisms by which RVFV invades the CNS following peripheral exposure, using novel rodent CNS infection models...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $636,101 to the University of Texas Medical Branch at Galveston (UTMB) to investigate the RNA packaging mechanisms of Rift Valley Fever Virus (RVFV). The key objectives are to elucidate how the segmented RVFV genome is efficiently packaged and co-packaged into viral particles, which is critical for understanding RVFV...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $516,900.00 to Immport Therapeutics Inc. (doing business as Antigen Discovery Inc.) to conduct research on humoral immunity to enteric viruses among infants and mothers in Bangladesh. The research aims to discover specific antibody correlates of protection from infant viral diarrhea caused by five major enteric human...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $453,750 to Tufts University School of Medicine to study how certain bacteriophages (viruses that infect bacteria) evade the protective mechanisms of bacteria, including some deadly pathogens like Vibrio cholerae. The project aims to determine the counter-defense mechanisms used by these phages and identify the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) is focused on understanding how the commensal bacteria Turicibacter sanguinis can protect against severe diarrheal disease caused by the intestinal pathogen Citrobacter rodentium. The $262,410 award, with a project period from Aug 1, 2025 to Jul 31, 2027, will support research at Vanderbilt University Medical Center to investigate the role of specific...